About
Ascilion is the world leader in sampling of dermal interstitial fluid (dISF). A pioneer within hollow microneedle technology since 2012, Ascilion has developed the only solution available for sampling of practical amounts of pure dISF, enabling complete quantitative biomarker evaluation. Ascilion's product PELSA is painless, quick, easy to use and leaves no residual mark on the skin. PELSA is available for research use and for pharmaceutical or cosmetic testing applications.
Technologies
OutlookMicrosoft Office 365Amazon AWSWordPress.orgMobile FriendlyGoogle Tag ManagerReviews
Keywords
pharmaceuticalsbiomarker researchb2bhealthcare equipment & suppliesregulatory compliancebiomarker detectionbiomarker detection in skindiagnosticsdiagnostic microneedlesbiomarker analysismedical equipment and supplies manufacturingbiomarker biomarkersimmunology researchbiomarker profiling in skindermal interstitial fluid biomarkerssilicon microneedlesmems fabricationhollow microneedlesmedical device developmentchronic urticaria samplingservicesbiotechnologybiomolecule extraction from skinclinical trialsmedical devicesdigital healthsilicon chipmedical technologyex vivo skin modelsmicro-electro-mechanical systems
Company Information
- Employees11
- Founded2012
- Total Funding$2229990
Location
22 Isafjordsgatan, Stockholm, Stockholm County, Sweden, 164 40
